Medtronic won the EU CE Mark for its MiniMed 780G closed loop insulin pump that features both Medtronic’s own SmartGuard algorithm and MD-Logic, an algorithm developed by DreaMed Diabetes, a small Israeli firm. The system, indicated to be used by patients with type 1 diabetes between ages 7 and 80, automatically delivers both basal insulin and correcting boluses every five minutes, if necessary.
Read more here.
![[Cybersixgill in Accesswire] Cybersixgill delivers the industry’s first end-to-end vulnerability exploit intelligence solution](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
